These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9432026)

  • 1. A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates.
    Li N; Goodall AH; Hjemdahl P
    Br J Haematol; 1997 Dec; 99(4):808-16. PubMed ID: 9432026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering.
    Li N; Goodall AH; Hjemdahl P
    Cytometry; 1999 Feb; 35(2):154-61. PubMed ID: 10554171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein IIb/IIIa inhibition attenuates platelet-activating factor-induced platelet activation by reducing protein kinase C activity.
    Hu H; Zhang W; Li N
    J Thromb Haemost; 2003 Aug; 1(8):1805-12. PubMed ID: 12911597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function?
    Klinkhardt U; Harder S
    Semin Thromb Hemost; 2005; 31(4):400-3. PubMed ID: 16149016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of fixatives on flow cytometric measurements of platelet P-selectin expression and fibrinogen binding.
    Hu H; Daleskog M; Li N
    Thromb Res; 2000 Nov; 100(3):161-6. PubMed ID: 11108903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab--preclinical and clinical studies.
    Kling D; Stucki C; Kronenberg S; Tuerck D; Rhéaume E; Tardif JC; Gaudreault J; Schmitt C
    Thromb Res; 2013 May; 131(5):401-10. PubMed ID: 23522853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation of platelet-neutrophil mediated by platelet-activating factor].
    Guo NJ; Chang YL; Xiao DJ; Huang P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):447-51. PubMed ID: 15972139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of circulating platelet-leukocyte conjugates: a sensitive flow cytometric assay well suited for clinical studies.
    Hagberg IA; Lyberg T
    Platelets; 2000 May; 11(3):151-60. PubMed ID: 10938891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of activated platelets and platelet-leukocyte aggregates in horses.
    Weiss DJ; Evanson OA
    Am J Vet Res; 1997 Aug; 58(8):823-7. PubMed ID: 9256963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.
    Zhao L; Bath PM; May J; Lösche W; Heptinstall S
    Platelets; 2003; 14(7-8):473-80. PubMed ID: 14713516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
    Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
    J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry.
    Li N; Hu H; Hjemdahl P
    Thromb Res; 2003; 111(3):165-70. PubMed ID: 14678815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro hypothermia enhances platelet GPIIb-IIIa activation and P-selectin expression.
    Faraday N; Rosenfeld BA
    Anesthesiology; 1998 Jun; 88(6):1579-85. PubMed ID: 9637652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise-induced platelet and leucocyte activation is not enhanced in well-controlled Type 1 diabetes, despite increased activity at rest.
    Hu H; Johansson BL; Hjemdahl P; Li N
    Diabetologia; 2004 May; 47(5):853-9. PubMed ID: 15095037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential binding of platelets to monocytes over neutrophils under flow.
    Ahn KC; Jun AJ; Pawar P; Jadhav S; Napier S; McCarty OJ; Konstantopoulos K
    Biochem Biophys Res Commun; 2005 Apr; 329(1):345-55. PubMed ID: 15721313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
    Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
    Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA.
    Dardik R; Savion N; Kaufmann Y; Varon D
    Br J Cancer; 1998 Jun; 77(12):2069-75. PubMed ID: 9649116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-selectin expression on platelets determines size and stability of platelet aggregates.
    Merten M; Thiagarajan P
    Circulation; 2000 Oct; 102(16):1931-6. PubMed ID: 11034941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.